Novo Nordisk and Medtronic to integrate diabetes technology

Novo Nordisk has teamed up with Medtronic to provide integrated digital solutions for people with diabetes, allowing dosing data from the Danish pharma’s insulin pens to be shared with the

Xeris’ severe low blood sugar pen gets FDA approval

North American Prefilled Syringes Market to achieve 10% CAGR...

Prefilled Syringes Market to cross $9.7bn by 2025

Mylan’s Lantus biosimilar held up by manufacturing issue

Heart failure results could unlock key market for Farxiga - ...

AstraZeneca doesn’t quite know why its diabetes drug Farxiga is also working in patients with heart failure – but what it does know is that, if approved in this new use on this basis, it co

FDA fast-tracks AZ's Farxiga in potential new CKD indication

The FDA has fast-tracked AstraZeneca’s Farxiga in a potential new use, to delay progression of renal failure and prevent cardiovascular death and renal death in patients with chronic kidney